Radiographic patterns,Clinical course and risk factors of pneumonitis in patients with advanced non small cell lung cancer treated with pembrolizumab or nivolumab

Trial Profile

Radiographic patterns,Clinical course and risk factors of pneumonitis in patients with advanced non small cell lung cancer treated with pembrolizumab or nivolumab

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Nov 2017

At a glance

  • Drugs Nivolumab (Primary) ; Pembrolizumab (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Nov 2017 New trial record
    • 18 Oct 2017 Results assessing radiographic patterns, clinical course and risk factors of pneumonitis, presented at the 18th World Conference on Lung Cancer.
    • 18 Oct 2017 Results (n=134) presented at the 18th World Conference on Lung Cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top